Hypertension is a serious public health problem in Morocco. The objective of this pilot study was to estimate the salt intake of Moroccan adults by measuring 24-hour urinary sodium excretion. Methods: 132 participants were recruited from the central region of Morocco.
Background:
High salt consumption may predispose individuals to high blood pressure and increase the risk of non-communicable diseases; especially cardiovascular diseases [1] [2] [3] . In a recent study, it has been estimated that 1.65 million cardiovascular deaths in 2010 could be attributed to the high salt consumption [4] . According to World Health Organization (WHO) , cardiovascular diseases (CVD) will become the leading cause of Disability Adjusted Life Years (DALYs) in 2020 [5] and more significantly, 80% of this global burden will occur in low and middle income countries [6] .
Reduction of sodium intake has been established as a lifestyle change which is recommended to reduce cardiovascular diseases (CVD) mainly by decreasing blood pressure (BP) level [7, 8] . Thus, WHO has recommended salt reduction as a top priority to prevent Non-Communicable Diseases and has considered this a public health target [9] .
In Morocco, the prevalence of hypertension in adults was estimated to 33.6 % in 2000 [10] . More recently, the WHO estimated the prevalence of hypertension in Morocco in 2008 to 41.2 % [5] , and 34 % of CVD in 2014 [11] .
The exact average amount of salt consumption in Morocco remains unknown. But, given the adverse impact of excessive salt consumption on health and particularly on blood pressure levels and cardiovascular diseases, WHO-EMRO has recommended a research project to estimate the sodium intake in Morocco and in other countries in the region of the East Mediterranean. Therefore, the aim of this pilot study was to measure 24-hour urinary sodium excretion in order to estimate the salt intake in the central region of Morocco.
Methods: Sample
A total of 132 participants (64 men and 68 women) were recruited from the central region of Morocco characterized by a varied climate and ethnicity of their population. Participants were healthy adults aged between 24 and 64 years with no history of renal disease.
Data collection:
The individual information of the participants was collected using a socio-demographic questionnaire. Sodium and potassium intake were estimated by measuring 24-hour urinary sodium and potassium excretion. Samples have been collected between March and June 2014. Similar temperatures were recorded during the period of this study. Verbal instructions were given to the participants for the 24-hour urine collection; The first urine of the day was discarded and all urine over the following 24 hours was collected in 5 liters plastic containers (with 1g of boric acid) [12] .
Body weight was measured using Omron body composition monitors (BF511) and Height was measured using SECA stadiometer for all the participants. Body Mass Index (BMI) was calculated and used to determine the anthropometric status of the participants. Blood pressure (BP) was recorded 3 times for each participant.
Urinary biochemical testing: Sodium, potassium and creatinine were measured by dry chemistry methods using Vitros 250 Chemistry System (Ortho Clinical Diagnostics). All the analyses were realized in a certified laboratory. Urinary creatinine was measured to discard incorrect urine collection.
Statistical analysis: Statistical analysis was done using CDC's statistical package Epi Info version 7. Data were described as means ± standard deviation for continuous variables. One-way ANOVA was used to compare the data means between both genders. Statistical significance level was set at α = 0.05.
Results:
A total of 128 participants accepted to collect their 24-hour urine samples. The mean age of the participants was 44 ± 12, range 24-65 years. The mean ages were 47 ± 11 years and 43 ± 12 years for men and women respectively (table 1). Ten samples were discarded from the analysis due to incorrect urine collection. Otherwise, the mean urine volume was 1125.5 ± 553.0 milliliters (n=118) with a range of (520-3300 ml). Our results showed that 34.11% of the participants were overweight (BMI between 25 and 30) and 20.93% were obese (BMI > 30) (table 2). Table 3 shows 24-hour urine excretion of sodium, potassium, creatinine and Na/K ration were particularly higher in men than in women. The mean of sodium excretion was 2779.1±1334.9 mg/day, which 1428.8±799.9 mg/day in men and 1325.0±437.9 mg/day in women. Data showed that 71.2% of the participants had intakes of over 5 g of salt (NaCl)/day (2000 mg of Na/day recommended). Moreover, the general average of potassium excretion was 35.04 ± 16.57 mEq/day. No significant differences were observed between men and women (Table 1) .
Discussion:
24-hour urinary sodium excretion is regarded as the best way to measure sodium intake of an individual [13] . Thus, alternative dietary methods have mostly been used in studies of the relation between sodium intake and cardiovascular disease.
This pilot study showed that mean values of 24 h urinary sodium excretion for all participants was 2779 ± 1377 mg (120 mEq ± 58), which 2928 ± 1227 mg in men (range 1058-6613 mg) and 2640 ± 1427 mg in women (range 392-6431 mg), that is higher than 2000 mg/day recommended by WHO for males and females (2000 mg/day) [14] .
However, salt consumption was estimated considering all sodium ingested as NaCl [15] because the 24-hour urinary sodium excretion can estimate 85-90% of dietary intake of sodium from all sources. In our report, urinary salt excretion was 6.95 g/day; however if the approximately 15% non-renal loss [16] were to be included, the overall salt intake would be 8.11 g/day. Moreover, our data showed that 71.2% of participants had a daily salt intake more than 5 g NaCl/day, and only 28.8% that are below the WHO recommendation of 5g/day [17] . Also, the daily individual average of bread consumption in Morocco is about 500 g [18] which is the equivalent of a daily intake of 8 to 9 g of salt through bread alone [19] .
Our data showed that 24-hour mean excretion of potassium was 1350 ± 642 mg (35 mEq ± 16), which indicates that potassium intake was low in both sexes of this sample (1429 ± 800 mg and 1325 ± 438 mg in men and women respectively), which could only amplify the burden of disease to which contributes the high sodium consumption [20] .
As another study [21] , we found that Na + and K + excretions were higher in men than in women, which confirms observations in other countries [22, 23] , that the intake of sodium is higher than the daily recommendations while potassium is below them, 2 g and 3.51 g, respectively [17, 24] .
Furthermore, potassium has been recognized as a protective factor for hypertension and a proposed modifier of the association between sodium intake and CVD [25] . Moreover, high potassium intake may have the greatest effect when salt intake is high, and it was associated with a lower risk of death and cardiovascular events [26] .
Recently, it has been reported that high intake of sodium is not associated with higher BP in people who have an increased intake of potassium [27] . Our results showed that Na/k ratio was 4 times higher in this sample than what is recommended by WHO [28] which could mean a higher cardiovascular risk for this population. A Chinese study found that the Na/k ratio was 3 times higher than recommendation, and they found that Na/K ratio has a stronger association with hypertension than does sodium or potassium intake alone [29] .
Several epidemiological reports have shown a relationship between sodium and potassium intake and cardiovascular disease and mortality in the general population [22, 30] . In this study, we found that urinary sodium excretion was higher than WHO recommendation, which could participate at the hypertension prevalence in Morocco [5] .
Studies have estimated that decreasing salt intake from 10 g to 5 g per day would reduce overall stroke rate by 23% and CVD by 17% [31] . A recent meta-analysis has reported a small salt reduction of 2.0-2.3 g/day was associated with a 20% decrease in cardiovascular events [32] .
Efforts should be invested in raising awareness about the dangers of a diet rich in sodium and about strategies to reduce salt intake in Morocco.
Conclusion:
The high sodium intake alongside with the low potassium intake reported in this study could both contribute to the high prevalence of hypertension, CVD, stroke and CHD in Morocco.
Thus, reducing sodium should be a priority on the public health strategy agenda in Morocco.
Strategies should include intensive public education by emphasizing; salt reduction during cooking and at the table and by evaluating and monitoring the population sodium and potassium consumption and sources in the diet. There is a need for concerted action from government, civil society, public health experts, academia, and food and beverage industries.
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What is already known on this topic?
High salt consumption may predispose individuals to high blood pressure In Morocco, the prevalence of hypertension in adults was estimated to 33.6 % in 2000
Reduction of sodium intake has been established as a lifestyle change which is recommended to reduce cardiovascular diseases
What this study adds?
Our data showed that 71.2% of participants had a daily salt intake more than 5 g NaCl/day, and only 28.8% that are below the WHO recommendation of 5g/day.
Our data showed that 24-hour mean excretion of potassium was 1350 ± 642 mg (35 mEq ± 16), which indicates that potassium intake was low than recommendation Reducing sodium should be a priority on the public health strategy agenda in Morocco.
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